Austco Healthcare Ltd

As of June 30, 2026, Austco Healthcare Ltd carries a market capitalization of 93.69M, placing it among publicly traded companies globally. Its enterprise value stands at 81.36M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Austco Healthcare Ltd's next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2026, Austco Healthcare Ltd has 374.75M shares outstanding.

As of June 30, 2026, Austco Healthcare Ltd trades at a trailing price-to-earnings ratio of 10.34. The price-to-sales ratio is 0.99, and the price-to-book ratio stands at 1.51.

As of June 30, 2026, Austco Healthcare Ltd trades at an EV/EBITDA multiple of 5.52 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.86 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 7.56 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 81.36M versus a market cap of 93.69M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Austco Healthcare Ltd maintains a current ratio of 2.14, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.35, indicating elevated leverage, while an interest coverage ratio of 1,637.00 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Austco Healthcare Ltd posted a return on equity (ROE) of 15.82, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 13.53 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.03, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 14.82, useful for judging operating efficiency across full business cycles. Inventory turnover of 4.27 indicates how many times Austco Healthcare Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Austco Healthcare Ltd recorded 2.58M in income tax expense. That works out to an effective tax rate of 22.26, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 11.58M, leaving 9.01M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Austco Healthcare Ltd's stock has declined approximately 30.49% over the past 52 weeks. The 50-day moving average sits at 0.25, while the 200-day moving average is 0.29.

Over the twelve months ended June 30, 2026, Austco Healthcare Ltd generated 94.24M in revenue and converted that into 9.01M in net income, yielding earnings per share of 0.02. EBITDA reached 14.73M, while operating income came in at 10.76M.

As of June 30, 2026, Austco Healthcare Ltd holds 16.28M in cash and equivalents against 3.95M in total debt, resulting in a net debt position of -16.14M. Total book value stands at 62.12M, with working capital of 26.78M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Austco Healthcare Ltd posted a gross margin of 53.36, reflecting its pricing power and cost economics. The operating margin of 11.42 and net profit margin of 9.56 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield reaches 1.52, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Austco Healthcare Ltd shareholders.

Austco Healthcare Ltd's most recent stock split took place on May 1, 2024.

As of June 30, 2026, Austco Healthcare Ltd has an Altman Z-Score of 4.92, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.